Clinical Trials Browser

Phase 3 × Interventional × Small Cell Lung Carcinoma × Clear all

NCT03043872 2026-04-22

CASPIAN

Phase 3 Active not recruiting

987 enrolled 42 charts 1 FDA

Small Cell Lung Carcinoma

NCT07099898 2026-04-22

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Phase 3 Recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT06646276 2026-04-21

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06992609 2026-04-21

ALBORAN

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT07472517 2026-04-20

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT07502300 2026-04-20

A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT06500026 2026-04-17

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT07005128 2026-04-16

DeLLphi-312

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06117774 2026-04-15

DeLLphi-306

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT04256421 2026-04-03

SKYSCRAPER-02

Phase 3 Completed

490 enrolled 33 charts

Small Cell Lung Carcinoma

NCT04804644 2026-04-03

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Phase 3 Recruiting

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06840704 2026-04-02

Relief

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Esophagitis, Small Cell Lung Carcinoma

NCT07015892 2026-03-31

ESCALADOR

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT07218146 2026-03-13

DLLEVATE

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT05091567 2026-03-10

IMforte

Phase 3 Active not recruiting

660 enrolled 23 charts 2 FDA

Small Cell Lung Carcinoma

NCT05153239 2026-03-09

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT07010263 2026-03-05

AK112-311

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06203210 2026-03-02

IDeate-Lung02

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT04665856 2026-02-13

SKYSCRAPER-02C

Phase 3 Active not recruiting

123 enrolled 26 charts

Small Cell Lung Carcinoma

NCT06712355 2026-02-13

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Phase 3 Recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05223647 2026-01-28

TRIPLEX

Phase 3 Terminated

Neoplasms, Small Cell Lung Carcinoma

NCT07365241 2026-01-26

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Phase 3 Not yet recruiting

Neoplasms, Small Cell Lung Carcinoma

NCT05353257 2026-01-13

A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT05740566 2026-01-05

DeLLphi-304

Phase 3 Active not recruiting

509 enrolled 11 charts 2 FDA

Small Cell Lung Carcinoma

NCT07189455 2026-01-05

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06211036 2025-12-17

DeLLphi-305

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT04063163 2025-12-09

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

Phase 3 Completed

585 enrolled 14 charts

Small Cell Lung Carcinoma

NCT03703297 2025-11-21

ADRIATIC

Phase 3 Active not recruiting

730 enrolled 19 charts 2 FDA

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06457906 2025-07-16

SHARP

Phase 3 Recruiting

Brain Neoplasms, Small Cell Lung Carcinoma

NCT05224141 2025-07-08

KEYVIBE-008

Phase 3 Active not recruiting

460 enrolled 18 charts

Small Cell Lung Carcinoma

NCT04624204 2025-07-02

MK 7339-013

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT06954246 2025-06-18

A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT04588246 2025-06-06

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Phase 3 Terminated

19 enrolled 19 charts

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04155034 2025-05-25

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT04774380 2025-05-23

LUMINANCE

Phase 3 Completed

152 enrolled 17 charts

Small Cell Lung Carcinoma

NCT06961201 2025-05-07

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT04005716 2025-02-28

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Phase 3 Completed

457 enrolled 20 charts

Small Cell Lung Carcinoma

NCT03088813 2025-02-19

RESILIENT

Phase 3 Completed

491 enrolled 24 charts

Small Cell Lung Carcinoma

NCT06612151 2025-02-11

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06789796 2025-02-11

a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT02349412 2025-02-07

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Phase 3 Completed

405 enrolled 11 charts

GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anxiety Disorders, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Depression, Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT04012606 2025-01-16

Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer

Phase 3 Completed

Small Cell Lung Carcinoma

NCT06496048 2024-12-12

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT04830813 2024-12-09

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Phase 3 Completed

Small Cell Lung Carcinoma

NCT06719336 2024-12-05

Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT05566041 2024-10-31

REPLATINUM

Phase 3 Active not recruiting

Small Cell Lung Carcinoma

NCT06498479 2024-10-16

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06581380 2024-09-03

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT06526624 2024-07-30

A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

Small Cell Lung Carcinoma

NCT04028050 2024-07-16

MAURIS

Phase 3 Completed

Small Cell Lung Carcinoma